Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, GG; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R.
ZOLEDRONIC ACID (ZOL) IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (ERBC) RECEIVING ADJUVANT ENDOCRINE THERAPY: MULTIVARIATE ANALYSIS OF EFFICACY DATA FROM THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12
ANN ONCOL. 2008; 19: 44-44.-33rd European-Society-for-Medical-Oncology Congress; SEP 12-16, 2008; Stockholm, SWEDEN.
[Keynote lecture]
Web of Science